← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2015Last known activity
Nov 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 14 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (23)
- NCT06714695CollaboratorN/ANov 1, 2024
- NCT06414759Sponsor investigatorPhase 4Jul 1, 2024
- NCT06426199CollaboratorPhase 4Jan 17, 2024
- NCT05872542Sponsor investigatorPhase 4Jun 1, 2023
- NCT05671497CollaboratorPhase 2/Phase 3Nov 1, 2022
- NCT05671497Reponsible party - principal investigatorPhase 2/Phase 3Nov 1, 2022
- NCT05170893Reponsible party - principal investigatorN/AJan 17, 2022
- NCT04792021Overall official - principal investigatorPhase 3Mar 9, 2021
- NCT04792021CollaboratorPhase 3Mar 9, 2021
- NCT04792021Study directorPhase 3Mar 9, 2021
- NCT04739345Reponsible party - principal investigatorN/ADec 1, 2020
- NCT04739345Overall official - principal investigatorN/ADec 1, 2020
- NCT04739345CollaboratorN/ADec 1, 2020
- NCT04575948Lead sponsorPhase 2/Phase 3Nov 30, 2020
- NCT05921942Reponsible party - principal investigatorPhase 3Apr 15, 2020
Details
- Last known activity
- Nov 1, 2024